BMC Medical Co., Ltd. (SHE:301367)

China · Delayed Price · Currency is CNY

40.39

-0.79 (-1.92%)

Jun 17, 2026, 4:00 PM EDT

-28.87% (1Y)

Market Cap	5.03B -37.2%
Revenue (ttm)	1.20B +31.3%
Net Income	192.15M +8.3%
EPS	1.54 +8.7%
Shares Out	124.42M
PE Ratio	26.19
Forward PE	17.92
Dividend	0.47 (1.14%)
Ex-Dividend Date	May 28, 2026

Volume	1,269,940
Open	41.27
Previous Close	41.18
Day's Range	40.20 - 41.27
52-Week Range	40.20 - 74.59
Beta	0.47
Analysts	Strong Buy
Price Target	69.29 (+71.55%)
Earnings Date	Aug 20, 2026

About BMC Medical

BMC Medical Co., Ltd. researches, develops, manufactures, and supplies medical equipment and consumable in the field of respiratory health in China. It offers sleep-disordered breathing (SDB) diagnostic devices, non-invasive ventilators, high-flow nasal cannula oxygen therapy devices, oxygen concentrator, and respiratory consumables, such as various types of masks, breathing tubes, etc., as well as PAP devices and CPAP masks. The company also provides snoring, sleep apnea, asthma, and chronic obstructive pulmonary disease solutions. BMC Medical... [Read more]

Industry Medical Instruments & Supplies

Sector Healthcare

Founded 2001

Employees 923

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 301367

Full Company Profile

Financial Performance

In 2025, BMC Medical's revenue was 1.16 billion, an increase of 37.46% compared to the previous year's 843.48 million. Earnings were 225.66 million, an increase of 45.23%.

Financial Statements

Analyst Summary

According to 2 analysts, the average rating for 301367 stock is "Strong Buy." The 12-month stock price target is ¥69.29, which is an increase of 71.55% from the latest price.

Price Target

¥69.29

(71.55% upside)

Analyst Consensus: Strong Buy

Stock Forecasts